Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve This is to intimate ....

MANUFACTURER OF BULK DRUGS & IMPORTERS OF SOLVENTS & CHEMICALS H.O: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 : (022) 23455543 Email: corporate@aareydrugs.com REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE (02525) 271049 Email: info@aareydrugs.com CIN:L99999MH1990PLC056538 Date: 07th August, 2026 BSE Limited National Stock Exchange of India Limited The Manager, Exchange Plaza Corporate Service Department BandraKurla Complex, P.J. Towers, Dalal Street, Bandra (E), Mumbai- 400 001 Mumbai – 400051 Scrip Code: 524412 NSE Symbol: AAREYDRUGS Subject: Intimation of Board Meeting. Dear Sir/Ma’am, This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 14th August, 2026 to transact the following business: 1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarter ended 30th June, 2026. 2. Any other matter with consent of the Chairman. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, as amended from time to time, the trading window of the Company has been closed from July 1, 2026 and shall remain closed till 48 hours from the announcement/declaration of the Unaudited Financial Results. Please take a note of the same and oblige. Thanking you, Yours faithfully, For AAREY DRUGS & PHARMACEUTICALS LIMITED Nimit Ghatalia Director DIN: 07069841